MétaCan
Menu
← Back to cohort

Impact of intermittent and maintenance chemotherapy on outcomes in metastatic colorectal cancer.

2016· article· en· W2522739347 on OpenAlexaff
Jonathan M. Loree, Sean K. R. Tan, Laurence Lafond, Hagen F. Kennecke, Winson Y. Cheung

Bibliographic record

VenueJournal of Clinical Oncology · 2016
Typearticle
Languageen
FieldMedicine
TopicColorectal Cancer Treatments and Studies
Canadian institutionsBC Cancer Agency
Fundersnot available
KeywordsMedicineColorectal cancerRegimenInternal medicineChemotherapyChemotherapy regimenCohortProportional hazards modelQuality of life (healthcare)PopulationUnivariate analysisOncologyPropensity score matchingSurgeryCancerMultivariate analysis

Abstract

fetched live from OpenAlex

6566 Background: With improved survival, clinicians managing metastatic colorectal cancer (mCRC) increasingly consider intermittent chemotherapy (IC) where patients receive a complete treatment break (TB) or maintenance chemotherapy (MC) where parts of a combination regimen are omitted. These modifications can improve quality of life (QoL) but their impact on outcomes is poorly understood. Methods: Using a population-based cohort of mCRC patients (pts) diagnosed from 2008 to 2010, we aimed to describe use of IC and MC and to compare median overall survival (mOS) in pts with and without these treatment modifications. IC was defined as TB intervals of ≥ 45 days without any cytotoxic agents while MC was defined as omission of one cytotoxic agent for ≥ 1 cycle. We examined outcomes using Kaplan-Meier methods, Cox regression, and propensity-score adjusted analyses. Results: Among 1249 mCRC pts, 279 (22%) underwent IC and had ≥ 1 TB, with median duration of 91 (IQR 63-158) days. TBs occurred at a median of 127 (IQR 57-234) days from initiation of a line of therapy and most pts (71%) only received 1 TB. In the 617 pts receiving a combination regimen, 120 (19%) had periods of MC, of which 68 (57%) had re-introduction of the omitted agent. On univariate analyses, patients undergoing IC (mOS 39 vs 23 months, P< 0.001) or MC (mOS 36 months vs 24 months, P= 0.0015) demonstrated better OS. In patients on MC, OS improvement was noted when the agent was restarted (mOS 41 months vs 24 months, P= 0.0073), but not without resumption (mOS 36 vs 24 months, P= 0.051). Using propensity scores and stratifying by treatment regimen, IC was not associated with altered OS (P > 0.05 across all regimens). In multivariate analysis adjusting for age, gender and regimen, MC was correlated with improved OS (HR 0.71, 95% CI 0.58-0.88, P= 0.002). When considering whether an omitted agent was re-introduced, MC with re-escalation (HR 0.68 95% CI 0.49-0.96, P= 0.027) was associated with improved OS, but not MC without re-escalation (HR 0.67 95% CI 0.50-0.91, P= 0.10). Conclusions: In patients with mCRC, IC and MC are reasonable options to maintain QoL and do not appear to negatively impact OS in carefully selected patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.102
GPT teacher head0.507
Teacher spread0.405 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicColorectal Cancer Treatments and Studies→French-language works237,207→